<DOC>
	<DOCNO>NCT00482157</DOCNO>
	<brief_summary>After diagnosis prostate cancer , many men alter lifestyle diet use various supplement attempt retard growth cancer . While limited data use diet supplement alter risk prostate cancer , even less known regard ability diet supplement alter progression . For men elect active surveillance , investigator propose investigate ability vitamin D retard growth prostate cancer .</brief_summary>
	<brief_title>Calcitriol Placebo Men Prostate Cancer Active Surveillance</brief_title>
	<detailed_description>Men randomize two arm total 24 subject : calcitriol alone ( DN101 , 45 microgram weekly ) placebo . Baseline laboratory assay , include serum PSA , serum urine calcium creatinine , perform EPIC questionnaire ( expanded prostate cancer index composite , validated HRQOL tool prostate cancer patient ) complete . Patients also undergo prostate needle biopsy [ 4 core take transrectal ultrasound ( TRUS ) guidance ] establish baseline level gene expression . Follow-up end 2 week ( prior third dose ) include history physical , repeat baseline blood urine test . Follow-up 3 month include history physical , repeat blood urine test , EPIC questionnaire . At 6 month , addition history physical , blood urine test , EPIC questionnaire , TRUS-guided prostate needle biopsy perform . This standard 12-core scheme 4 core use laboratory analysis . Renal ultrasounds perform men calcitriol arm look stone . Patients show evidence clinical progression offer remain study , designate treatment arm , additional 6 month . Any patient exhibit clinical progression time withdrawn study offer standard treatment option . For patient remain study 12 month , end-of-study biopsy request ( 12-core scheme 4 core use laboratory analysis )</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Untreated prostate adenocarcinoma extend biopsy ( &gt; 8 needle core systematic prostate biopsy ) within 1 year screen date PSA &lt; 10.0 ng/ml Gleason sum 6 &lt; 2 mm Gleason pattern 4 No 33 % biopsy core positive Prior concurrent treatment prostate cancer Use Finasteride , Dutasteride , Saw Palmetto Use NSAIDs , COX2 inhibitor and/or aspirin , soy vitamin D supplement 7 day one month prior study Kidney disease , hypercalcemia renal stone ECOG performance status &gt; 1 Uncontrolled hypertension , unstable angina , history transient ischemic attack ( TIA ) , history stroke .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>